10 Einträge von 145 mit factor vitamin
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Roger Egger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring berne | studies notre | with plus | that scientific | disease savoir | nous including | patients quality | clinical research | application initiated | products investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036321
erkannte Namen Roger Egger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring berne | studies notre | with plus | that scientific | disease savoir | nous including | patients quality | clinical research | application initiated | products investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036321
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Roger Egger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring savoir | studies plus | with scientific | that notre | disease berne | patients including | investigator research | products quality | clinical initiated | application nous |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036321
erkannte Namen Roger Egger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring savoir | studies plus | with scientific | that notre | disease berne | patients including | investigator research | products quality | clinical initiated | application nous |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036321
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Roger Egger | Grant Provider |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring savoir | studies plus | with scientific | that notre | disease berne | patients including | investigator research | products quality | clinical initiated | application nous |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036321
erkannte Namen Roger Egger | Grant Provider |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring savoir | studies plus | with scientific | that notre | disease berne | patients including | investigator research | products quality | clinical initiated | application nous |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036321
www.cslbehring.ch
Datum der Indexierung 17.02.2023 23:14:18
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring savoir | with scientific | studies notre | that including | disease plus | products research | nous berne | investigator quality | clinical patients | initiated application |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036321
erkannte Namen Grant Provider |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring savoir | with scientific | studies notre | that including | disease plus | products research | nous berne | investigator quality | clinical patients | initiated application |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036321
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring plant | first switzerland | with approval | plasma learn | approved award | patients drug | treatment immunglobulin | production market | factor bern | company more |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
factors in Lengnau. At least 300 new jobs will be created and, over a period of five years, an investment of over 400 million Swiss francs will be made. From 2019, three new recombinant coagulating factors will be produced and marketed around the wor vitamin K antagonists in adults with acute serious bleeding. In December, Kcentra® was also approved for reversing the effects of vitamin K antagonists on patients who require emergency surgery. CSL Behring markets Kcentra® as Ber
Text Inhalt Text aus URL
Log Metriken 32759
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring plant | first switzerland | with approval | plasma learn | approved award | patients drug | treatment immunglobulin | production market | factor bern | company more |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
factors in Lengnau. At least 300 new jobs will be created and, over a period of five years, an investment of over 400 million Swiss francs will be made. From 2019, three new recombinant coagulating factors will be produced and marketed around the wor vitamin K antagonists in adults with acute serious bleeding. In December, Kcentra® was also approved for reversing the effects of vitamin K antagonists on patients who require emergency surgery. CSL Behring markets Kcentra® as Ber
Text Inhalt Text aus URL
Log Metriken 32759
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Roger Egger | Grant Provider |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring scientific | with including | studies learn | that diseases | disease research | products your | clinical patients | health quality | investigator more | initiated application |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036330
erkannte Namen Roger Egger | Grant Provider |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring scientific | with including | studies learn | that diseases | disease research | products your | clinical patients | health quality | investigator more | initiated application |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036330
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring plant | first switzerland | with approval | plasma learn | approved award | patients drug | treatment immunglobulin | production market | factor bern | company more |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
factors in Lengnau. At least 300 new jobs will be created and, over a period of five years, an investment of over 400 million Swiss francs will be made. From 2019, three new recombinant coagulating factors will be produced and marketed around the wor vitamin K antagonists in adults with acute serious bleeding. In December, Kcentra® was also approved for reversing the effects of vitamin K antagonists on patients who require emergency surgery. CSL Behring markets Kcentra® as Ber
Text Inhalt Text aus URL
Log Metriken 32759
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring plant | first switzerland | with approval | plasma learn | approved award | patients drug | treatment immunglobulin | production market | factor bern | company more |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
factors in Lengnau. At least 300 new jobs will be created and, over a period of five years, an investment of over 400 million Swiss francs will be made. From 2019, three new recombinant coagulating factors will be produced and marketed around the wor vitamin K antagonists in adults with acute serious bleeding. In December, Kcentra® was also approved for reversing the effects of vitamin K antagonists on patients who require emergency surgery. CSL Behring markets Kcentra® as Ber
Text Inhalt Text aus URL
Log Metriken 32759
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring plant | first switzerland | with approval | plasma learn | approved award | patients drug | treatment immunglobulin | production market | factor bern | company more |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
factors in Lengnau. At least 300 new jobs will be created and, over a period of five years, an investment of over 400 million Swiss francs will be made. From 2019, three new recombinant coagulating factors will be produced and marketed around the wor vitamin K antagonists in adults with acute serious bleeding. In December, Kcentra® was also approved for reversing the effects of vitamin K antagonists on patients who require emergency surgery. CSL Behring markets Kcentra® as Ber
Text Inhalt Text aus URL
Log Metriken 32759
erkannte Namen Ria STAP | Norbert Heimberger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring plant | first switzerland | with approval | plasma learn | approved award | patients drug | treatment immunglobulin | production market | factor bern | company more |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
factors in Lengnau. At least 300 new jobs will be created and, over a period of five years, an investment of over 400 million Swiss francs will be made. From 2019, three new recombinant coagulating factors will be produced and marketed around the wor vitamin K antagonists in adults with acute serious bleeding. In December, Kcentra® was also approved for reversing the effects of vitamin K antagonists on patients who require emergency surgery. CSL Behring markets Kcentra® as Ber
Text Inhalt Text aus URL
Log Metriken 32759
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Roger Egger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring scientific | with including | studies diseases | that learn | products research | disease your | clinical patients | health quality | initiated more | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036330
erkannte Namen Roger Egger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring scientific | with including | studies diseases | that learn | products research | disease your | clinical patients | health quality | initiated more | application investigator |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036330
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Roger Egger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring scientific | with including | studies learn | that diseases | disease research | products your | clinical patients | health quality | investigator more | initiated application |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036330
erkannte Namen Roger Egger |
Subdomain:
extern (outbound) Link/Domain 7 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Investigator-Initiated Studies CSL Behring Investigator-Initiated Studies Primary Immunodeficiency (PI) Diseases
Kombination Keywords behring scientific | with including | studies learn | that diseases | disease research | products your | clinical patients | health quality | investigator more | initiated application |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX (Recombinant) Albumin Fusion Protein and Antihemophilic Factor (Recombinant) Single Chain, and our plasma products, Human Plasma Derived von Willebrand Factor (HP-vWF/FVIII) concentrate, Fibrinogen, and Prothrombin complex concentrate [huma Vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) Clinical studies and experience with PCCs for urgent reversal prior to emergency surgery or procedures in patients treated with VKAs or DOACs Acquired Bleeding Cli
Text Inhalt Text aus URL
Log Metriken 1036330